The X-linked hypophosphatemia market is estimated to be valued at USD 1.5 Bn in 2024 and is expected to reach USD 2.8 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031. https://www.zupyak.com/p/4487477/t/the-role-of-targeted-therapies-in-shaping-the-x-linked-hypophosphatemia-market